Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S4X pseudogene 3 (RPS4XP3) is classified as a human pseudogene—an inactive genetic element, related in sequence to the ribosomal protein S4X gene family, but not expressed as a functional protein[7][8][5]. It is formally registered under NCBI Gene ID 128580 and Ensembl ENSG00000214541[5][7], with alternate identifiers used in various genomics databases. Because it is a pseudogene, RPS4XP3 is not translated into protein, is generally considered genetically "silent," and does not serve as a therapeutic target, marker, or receptor in current pharmacological or clinical contexts. The name similarity to canonical ribosomal proteins can cause confusion; however, only functional protein-coding genes are considered legitimate molecular targets[7][8].
None applicable (not a functional protein or drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S4X pseudogene 3 (RPS4XP3).